What is the Sun Pharma Advanced Research Company Ltd share price today?

The share price of NSE:SPARC-EQ on 01 Oct 2026 (as of 15:04:56 IST) is ₹193.42.

What is the NSE:SPARC-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:SPARC-EQ 52 week high low range shows a high of ₹289 and a low of ₹108.

What is the Sun Pharma Advanced Research Company Ltd market cap?

As on 01 Oct 2026, Sun Pharma Advanced Research Company Ltd market cap is ₹63995700000.

What is the shareholding pattern of Sun Pharma Advanced Research Company Ltd Stock?

The shareholding pattern of Sun Pharma Advanced Research Company Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 65.67% Foreign Institutional Investors (FII): 3.9% Domestic Institutional Investors (DII): 0% Mutual Funds: 0.08% Retail & Others: 30.35% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Sun Pharma Advanced Research Company Ltd?

The Price-to-Earnings (PE) ratio of Sun Pharma Advanced Research Company Ltd is 4.0394, and the Price-to-Book (PB) ratio is 2.7779, as on 01 Oct 2026.

Sun Pharma Advanced Research Company Share Price

188.64+0.33 (+0.18%)

+43.09% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Login to analyze with FIA

1 Day

+0.18%

1 Week

+2.05%

1 Month

-2.34%

3 Month

-19.80%

6 Month

+30.55%

YTD

+40.30%

1 Year

+43.09%

5 Year

-35.77%

10 Year

-40.22%

Max

+121.41%

1D

1W

1M

3M

6M

YTD

1Y

5Y

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

186.27

182.51

182.00

136.72

108.00

High

190.90

198.20

212.00

238.39

289.00

About

Sun Pharma Advanced Research Company Limited (SPARC) is a clinical stage bio-pharmaceutical company focused on continuously improving standards of care for patients globally, through innovation in therapeutics and delivery. The Read more

Business Support

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

PFOCUSNSE

SAGILITYNSE

SYNGENENSE

INDGNNSE

HORIZONINDNSE

IGILNSE

NESCONSE

SPARCNSE

LEAPINDNSE

JUSTDIALNSE

LTP

1W Low

1W High

Market cap (₹)

290.3+8.35 (2.96%)

261.10

303.65

21,619Cr

45.3+2.11 (4.89%)

42.76

46.12

21,235Cr

386.1+14.15 (3.80%)

353.95

397.90

15,493Cr

598.3+12.3 (2.10%)

567.55

600

14,277Cr

48.08-0.96 (-1.96%)

47.52

49.90

13,971Cr

326.7+18.1 (5.87%)

307.85

328.40

13,885Cr

1045.9+9.4 (0.91%)

1027

1060

7,384Cr

188.64+3.79 (2.05%)

182.51

198.20

6,117Cr

136.09-6.19 (-4.35%)

134

145

5,927Cr

713.25+58.3 (8.90%)

644.15

719.70

5,789Cr

Sun Pharma Advanced Research Company Share Price

188.64+0.33 (+0.18%)

+43.09% past 1 Year

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Sun Pharma Advanced Research Company Share Price

188.64+0.33 (+0.18%)

+43.09% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years99%

Last year2518%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year553%

Stock Price CAGR

10 years-5%

5 years-8%

3 years-6%

1 year43%

Return on Equity

10 years28%

5 years28%

3 years52%

Last year277%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	99%	2518%
-	-	-	553%
-5%	-8%	-6%	43%
28%	28%	52%	277%

Peer Comparison

Symbol

PFOCUS

SAGILITY

SYNGENE

INDGN

HORIZONIND

IGIL

NESCO

SPARC

LEAPIND

JUSTDIAL

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
290.3	₹21619 Cr	187.05	-0.53	10.52	₹219 Cr
45.3	₹21235 Cr	21.38	0.46	3.18	₹925 Cr
386.1	₹15493 Cr	70.1	-0.22	16.72	₹317 Cr
598.3	₹14277 Cr	35.61	4.83	22.81	₹401 Cr
48.08	₹13971 Cr	—	-0.04	0.24	-₹198 Cr
326.7	₹13885 Cr	22.77	3.84	15.26	₹711 Cr
1,045.9	₹7384 Cr	17.72	14.19	66.2	₹413 Cr
188.64	₹6117 Cr	3.86	-0.64	49.12	₹1553 Cr
136.09	₹5927 Cr	95.08	2.05	6.05	₹62 Cr
713.25	₹5789 Cr	11.5	19.54	64.36	₹497 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
₹40 Cr	₹1853 Cr	₹8 Cr	₹8 Cr	₹10 Cr	₹27 Cr	₹15 Cr	₹13 Cr	₹17 Cr	₹17 Cr	₹14 Cr	₹21 Cr	₹24 Cr	₹48 Cr
₹24 Cr	₹2 Cr	₹0	₹1 L	₹9 Cr	₹0	₹19 L	₹4 L	₹2 Cr	₹4 Cr	₹6 Cr	₹8 Cr	₹10 Cr	₹11 Cr
₹64 Cr	₹1855 Cr	₹8 Cr	₹8 Cr	₹19 Cr	₹27 Cr	₹15 Cr	₹13 Cr	₹18 Cr	₹21 Cr	₹20 Cr	₹30 Cr	₹34 Cr	₹58 Cr
₹76 Cr	₹82 Cr	₹68 Cr	₹76 Cr	₹64 Cr	₹83 Cr	₹92 Cr	₹119 Cr	₹113 Cr	₹125 Cr	₹120 Cr	₹116 Cr	₹129 Cr	₹140 Cr
-₹10 Cr	₹1775 Cr	-₹57 Cr	-₹66 Cr	-₹43 Cr	-₹53 Cr	-₹74 Cr	-₹103 Cr	-₹92 Cr	-₹101 Cr	-₹96 Cr	-₹83 Cr	-₹92 Cr	-₹79 Cr
₹8 Cr	₹12 Cr	₹9 Cr	₹8 Cr	₹6 Cr	₹5 Cr	₹3 Cr	₹1 Cr	₹56 L	₹91 L	₹26 L	₹26 L	₹26 L	₹21 L
-₹21 Cr	₹1761 Cr	-₹80 Cr	-₹76 Cr	-₹52 Cr	-₹61 Cr	-₹79 Cr	-₹107 Cr	-₹96 Cr	-₹105 Cr	-₹100 Cr	-₹86 Cr	-₹95 Cr	-₹82 Cr
-₹21 Cr	₹1761 Cr	-₹80 Cr	-₹76 Cr	-₹52 Cr	-₹60 Cr	-₹80 Cr	-₹107 Cr	-₹96 Cr	-₹106 Cr	-₹100 Cr	-₹86 Cr	-₹95 Cr	-₹82 Cr

Balance Sheet

Consolidated

Standalone

₹

%

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023
—	—	—	—
₹32 Cr	₹32 Cr	₹32 Cr	₹32 Cr
₹1306 Cr	-₹249 Cr	₹93 Cr	₹480 Cr
₹1306 Cr	-₹249 Cr	₹93 Cr	₹480 Cr
₹1339 Cr	-₹217 Cr	₹126 Cr	₹513 Cr
₹0	₹100 Cr	₹0	₹0
-₹2 Cr	-₹2 Cr	-₹1 Cr	₹0
₹66 Cr	₹71 Cr	₹118 Cr	₹130 Cr
₹12 Cr	₹8 Cr	₹6 Cr	₹8 Cr
₹76 Cr	₹176 Cr	₹123 Cr	₹138 Cr
—	—	—	—
₹97 Cr	₹114 Cr	₹142 Cr	₹148 Cr
₹88 Cr	₹94 Cr	₹62 Cr	₹24 Cr
₹556 Cr	₹158 Cr	₹47 Cr	₹5 L
₹13 Cr	₹8 Cr	₹14 Cr	₹6 Cr
₹754 Cr	₹374 Cr	₹265 Cr	₹179 Cr
₹2169 Cr	₹333 Cr	₹514 Cr	₹830 Cr
₹85 Cr	₹85 Cr	₹84 Cr	₹84 Cr
₹556 Cr	₹258 Cr	₹47 Cr	₹5 L
—	—	—	—
₹144 Cr	₹158 Cr	₹157 Cr	₹146 Cr
₹59 Cr	₹59 Cr	₹50 Cr	₹40 Cr
₹85 Cr	₹99 Cr	₹108 Cr	₹106 Cr
₹50 L	₹56 L	₹1 Cr	₹2 Cr
₹121 Cr	₹128 Cr	₹68 Cr	₹65 Cr
₹29 Cr	₹26 Cr	₹25 Cr	₹178 Cr
₹306 Cr	₹307 Cr	₹244 Cr	₹375 Cr
—	—	—	—
₹0	₹0	₹2 Cr	₹291 Cr
₹8 Cr	₹16 Cr	₹16 Cr	₹33 Cr
₹1 Cr	₹2 Cr	₹155 Cr	₹112 Cr
₹1843 Cr	₹4 Cr	₹42 Cr	₹4 Cr
₹10 Cr	₹4 Cr	₹54 Cr	₹16 Cr
₹1862 Cr	₹26 Cr	₹269 Cr	₹455 Cr
₹1108 Cr	-₹348 Cr	₹4 Cr	₹276 Cr
₹2169 Cr	₹333 Cr	₹514 Cr	₹830 Cr
₹41	-₹7	₹4	₹16
₹41	-₹7	₹4	₹16

Cash Flow

Consolidated

Standalone

₹

%

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023
₹1553 Cr	-₹343 Cr	-₹387 Cr	-₹223 Cr
₹41 Cr	₹21 Cr	-₹11 Cr	₹7 Cr
-₹1865 Cr	-₹47 Cr	-₹27 Cr	₹141 Cr
-₹270 Cr	-₹369 Cr	-₹425 Cr	-₹74 Cr
-₹239 Cr	-₹360 Cr	-₹429 Cr	-₹69 Cr
-₹23 Cr	₹158 Cr	₹392 Cr	-₹548 Cr
₹261 Cr	₹199 Cr	₹42 Cr	₹617 Cr
-₹89 L	-₹3 Cr	₹5 Cr	-₹64 L
₹2 Cr	₹5 Cr	₹58 L	₹1 Cr
₹8 L	₹1 L	₹20,000	₹0
₹1 Cr	₹2 Cr	₹5 Cr	₹58 L

Fundamental Ratios

Consolidated

Standalone

No results found

Sun Pharma Advanced Research Company Share Price

188.64+0.33 (+0.18%)

+43.09% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Sun Pharma Advanced Research Company Share Price

188.64+0.33 (+0.18%)

+43.09% past 1 Year

Technical meters

Oscillators

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 0

Bearish signals: 6 out of 9 oscillators

RSI

43.52Sell

STOCH %K

21.02Neutral

MACD Level(12,26)

-3.34Sell

Ultimate Oscillator

30.45Sell

Aroon Oscillator

-56.00Sell

BOP

-0.12Sell

CCI

-90.49Neutral

Williams %R

-78.98Neutral

Momentum

-20.41Sell

Moving averages

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 2

Bearish signals: 7 out of 9 moving averages

EMA 9

190.40Sell

SMA 9

189.96Sell

EMA 21

193.64Sell

SMA 21

195.42Sell

EMA 50

198.72Sell

SMA 50

197.83Sell

EMA 200

184.88Buy

SMA 200

175.68Buy

WMA 20

192.84Sell

Pivot

Classic

Resistance 5

214.94

Resistance 4

208.67

Resistance 3

202.40

Resistance 2

196.13

Resistance 1

192.22

Pivot

189.86

Support 1

185.95

Support 2

183.59

Support 3

177.32

Support 4

171.05

Support 5

164.78

High & lows

1 Day

1 Week

1 Month

3 Months

6 Months

Year to Date

1 Year

3 Years

5 Years

10 Years

All Time

Low

186.27

182.51

182.00

136.72

108.00

81.00

35.17

High

190.90

198.20

212.00

238.39

289.00

472.80

532.00

593.96

Returns

+0.33

+3.79

-4.52

-46.56

+44.14

+54.19

+56.81

-38.81

-105.06

-126.91

+103.44

Beta

—

Std. deviation %

—

Sign in to view

Open a free Demat account in minutes to start investing and screening .

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
65.67%	65.67%	65.67%	65.67%	65.67%	65.67%
3.74%	3.90%	2.04%	2.04%	1.76%	1.48%
0.00%	0.00%	0.02%	0.02%	0.02%	0.02%
0.10%	0.08%	0.85%	0.76%	1.01%	0.94%
30.49%	30.35%	31.42%	31.51%	31.54%	31.89%

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
26 May 2026	Purchase	47.78 Cr	₹240.53	19.86 L	Bulk	0.612128	NSE
26 May 2026	Sell	45.67 Cr	₹240.86	18.96 L	Bulk	0.584224	NSE
25 May 2026	Sell	41.10 Cr	₹225.98	18.19 L	Bulk	0.560505	NSE
25 May 2026	Sell	54.54 Cr	₹227.61	23.96 L	Bulk	0.738402	NSE
25 May 2026	Purchase	50.43 Cr	₹227.43	22.17 L	Bulk	0.683243	NSE
25 May 2026	Purchase	41.09 Cr	₹227.12	18.09 L	Bulk	0.557461	NSE
25 May 2026	Purchase	57.45 Cr	₹226.90	25.32 L	Bulk	0.780262	NSE
25 May 2026	Sell	53.51 Cr	₹226.35	23.64 L	Bulk	0.72845	NSE
25 May 2026	Purchase	55.07 Cr	₹227.49	24.21 L	Bulk	0.745965	NSE
25 May 2026	Sell	50.45 Cr	₹227.54	22.17 L	Bulk	0.683243	NSE

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
10 Jun 2026	Promoter	Acquisition	—	65.67	0	—	3.85 Cr	19 May 2026	Pref. Allotment	25,16,25,095	SAST	29(2)	—
21 May 2026	Promoter Group	Acquisition	11.866699	100	150 Cr	₹38.95	3.85 Cr	19 May 2026	Preferential Offer	3,85,10,000	Insider Trading	—	Warrants
24 Dec 2024	Promoter	Pledge	—	—	0	—	19 L	- 26 Dec 2022	Creation	19,20,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	0	—	30.80 L	- 30 Nov 2022	Release	20,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	0	—	30.80 L	- 30 Nov 2022	Release	20,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	0	—	10 L	- 29 Aug 2022	Release	31,00,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	0	—	8.70 L	- 15 Jun 2022	Creation	36,70,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	0	—	4.30 L	- 20 Jun 2022	Creation	41,00,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	0	—	13 L	- 23 May 2022	Release	28,00,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	0	—	8 L	17 Feb 2021	Creation	41,00,000	SAST	Reg31	—

Sun Pharma Advanced Research Company Share Price

188.64+0.33 (+0.18%)

+43.09% past 1 Year

Sun Pharma Advanced Research Company Limited (SPARC) is a clinical stage bio-pharmaceutical company focused on continuously improving standards of care for patients globally, through innovation in therapeutics and delivery. The

Corporate Actions

Date

Type

Details

2016-03-16

Rights

5:116;245.0

2012-08-23

Rights

1:7;67.0

Company details

Registered office

Plot No.5 & 6/1, Savli G. I. D. C. Estate Savli - Vadodara Highway Manjusar Vadodara Gujarat PIN: 391775 Tel No: 0265- 2330815 Fax No: 0265- 2354897 Email: [email protected] Internet: www.sparc.life

Registrars

C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/

Management

Kajal Damania, Company Secretary & Compliance Officer

Robert J Spiegel, Non Executive Independent Director

Venkateswarlu Jasti, Non Executive Independent Director

Rekha Warriar, Non Executive Independent Director

Vidhi Shanghvi, Promoter & Non-Executive Director

Dilip S Shanghvi, Chairman

Details

BSE 532872

NSE SPARC

ISIN INE232I01014